A number of investment brokers have recently updated their price targets on shares of ChemoCentryx, Inc. (NASDAQ:CCXI). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

09/24/2015 – ChemoCentryx, Inc. had its “buy” rating reiterated by analysts at JP Morgan.

05/12/2015 – ChemoCentryx, Inc. was downgraded to “hold” by analysts at Zacks.

11/06/2014 – ChemoCentryx, Inc. was downgraded to “market perform” by analysts at Cowen.

01/13/2014 – Goldman Sachs began new coverage on ChemoCentryx, Inc. giving the company a “neutral” rating. They now have a USD 7 price target on the stock.

12/04/2013 – ChemoCentryx, Inc. was downgraded to “neutral” by analysts at Citigroup.

The share price of ChemoCentryx, Inc. (NASDAQ:CCXI) was down -0.98% during the last day of trading, with a day high of 2.20. 114946 shares were traded during the last session.

The stock’s 50 day moving average is 2.48 and its 200 day moving average is 4.75. The stock’s market capitalization is 89.59M. ChemoCentryx, Inc. has a 52-week low of 1.92 and a 52-week high of 9.46.

View other investors thoughts on ChemoCentryx, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.